Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease

Overview of attention for article published in Drug Design, Development and Therapy, February 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs: 4 blogs
twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 82 Dimensions

Readers on

mendeley: 133 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,887 followers.

RT @ClinicalRehab: DW. Most rehabilitation services will become involved in managing people with Huntington's disease. Tetrabenazine may he…

13 Aug 2019

Reply Repost Favourite

DW. Most rehabilitation services will become involved in managing people with Huntington's disease. Tetrabenazine may help chorea, but deutetrabenazine may be better - licenced in the US bt not in UK as far as I know. https://t.co/vD0TxywMof Probably safer

13 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.